Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1999 | 09-1999 | 06-1999 | 03-1999 | 12-1998 | |
| Sales | 2,820,500 | 2,585,200 | 2,341,600 | 2,255,600 | 2,635,400 |
| Cost of Goods | 565,200 | 548,200 | 491,100 | 493,500 | 119,600 |
| Gross Profit | 2,255,300 | 2,037,000 | 1,850,500 | 1,762,100 | 1,934,200 |
| Operating Expenses | 1,286,000 | 1,139,500 | 1,110,200 | 1,006,500 | 1,272,200 |
| Operating Income | 969,500 | 897,700 | 740,400 | 756,100 | 1,244,200 |
| Interest Expense | 51,000 | 45,900 | 43,000 | 43,900 | 43,900 |
| Other Income | 105,200 | 87,400 | 41,600 | -168,700 | -510,200 |
| Pre-tax Income | 1,023,700 | 939,200 | 739,000 | 543,500 | 690,100 |
| Income Tax | 237,400 | 206,600 | 162,600 | 92,100 | 131,600 |
| Net Income Continuous | 786,300 | 732,600 | 576,400 | 451,400 | 561,600 |
| Net Income Discontinuous | 0 | 0 | 0 | 174,300 | 5,700 |
| Net Income | $786,300 | $732,600 | $576,400 | $625,700 | $567,300 |
| EPS Basic Total Ops | 0.73 | 0.68 | 0.53 | 0.57 | 0.52 |
| EPS Basic Continuous Ops | 0.73 | 0.68 | 0.53 | 0.41 | 0.51 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 0.16 | 0.01 |
| EPS Diluted Total Ops | 0.71 | 0.67 | 0.52 | 0.56 | 0.51 |
| EPS Diluted Continuous Ops | 0.71 | 0.67 | 0.53 | 0.40 | 0.50 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 0.16 | 0.01 |
| EBITDA(a) | $1,068,800 | $1,013,700 | $852,400 | $868,500 | $1,375,800 |